IV Fluids Manufacturing Unit

Page 1

IV Fluid Manufacturing Business Available Reports on this Title –

http://meticulousbplans.com/product/iv-fluids-manufacturing-unit/

    

Business Feasibility Study Report Business Model Project Report Business Plan Detailed Project Report


Executive Summary and Analysis •

Intravenous fluids present a combination of nutrients that support patients to get essential nutrition. It helps in treating electrolyte imbalances, medications, transfusion of blood, rehydration and it also helps in chemotherapy.

The demand for Intravenous fluid is rising, because it is more effective than oral ingestion. The primary costumers for these manufacturing units are Hospitals, Clinics, Dialysis centers, Home care settings.

As per MBP analysis, the global Intravenous Fluid market size was valued at US$ 8,372.0 million in 2019, and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027).


Competitive Advantage & Pre-requisite Pre-requisite Revenue Generation Government Support

High Growth Feasibility

2 1 Eternal Market

3 Competitive Competitive Advantages Advantages

Skilled Employee

Business License

4 Fund Plan

5 Market Potential

Required Technical Expert


Market Dynamics Growth drivers • Increasing prevalence of chronic diseases. • Growing acceptance of vitamin C intravenous for colorectal cancer.

Challenges • Stringent government regulations. • Ensuring patient safety.

Opportunities • More effective than oral ingestion. • Increasing government endorsement.

Threats • Ignorance of manufacturing guidelines may affect the patient safety.


Financial Summary •

Project – IV Fluids Manufacturing Unit

Product Type– Crystalloids, Colloids, Blood products , etc.

Initial Investment – 70 - 80 Lakh INR

Capital Investment – 35 - 45 Lakh INR


Project Profile – Project Details

    

Product Portfolio

Manpower Required

Legal Requirements

IV Fluid Manufacturing Business

Skilled & Executive Employee

Business & Industry Requirement

Product Portfolio

Employment Generation

List

Dextrose Albumin Mannitol RBC WBC, etc.

1.

Skilled and Unskilled Labor – XX

1.

PAN & TAN

2.

Driver – X

2.

MSME Registration

3.

Plant executive – X ( for Dock, Process, Product, Store & for Lab)

3.

Shop Act

4.

Supervisor – X

4.

GST

5.

Operator -X

5.

XXX

6.

Admin Executive – X (Admin, HR, Account & Finance)

6.

XXX

7.

Marketing Executive – x (Sales & Marketing)

7.

XXX

8.

Director – X (Admin, Operation, Marketing & Finance)

8.

XXX

9.

XXX

10. XXX


Start-up Budget and Production Details Production Details

Budget (INR) 1.

Pre-operative Expenses – XX,00,000

1.

Operation – 1st Year – XX%, Second Year – XX% and 3rd Year – XXX%

2.

Fixed Capital – XX,00,00,000

2.

Working Days – X00 Per Annum

3.

Working Capital ( X Month) – X,00,00,000

3.

Land Type – NA

4.

Total Investment – XX,00,00,000

4.

Power Requirement – XX – X00 Kw (x Phase)

5.

Cost Per Unit – XX INR

5.

Water Requirement – XX,000 LPD

6.

Price Per Unit – XX INR

6.

Transportation – XX, Km

7.

Profitability – XX %

8.

BEP – XX Years

9.

ROI – XX %

Slide Title


Recent News(timeline) & MBS Analysis •

Eurolife Healthcare, India's largest maker of intravenous (IV) fluid formulations, plans to expand into highly-regulated markets such as Europe and the US, on back of its acquisition of Teva's Intravenous Infusions plant in Hungary last month.

A Kerala-based health-tech startup - Evelabs came up with a smart IV therapy system “Dripo” that regulate and monitor IV drips.

12-year-old girl “Ella Casano” creates teddy bear cover for children’s hospital IV drips.


Meticulous Business Plans

Thank You For detailed reports and plans, Contact us on Following Details.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.